CD163 and pancreatic neoplasm: Our observations that CD163+ (M2) macrophages are more numerous in K17-positive intratumoral areas are consistent with previous studies in colorectal cancer [61] and align with work depicting CD163 CD+ T cells as promoter of biologic aggression in pancreatic cancer [64].